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Manipulation of the poultry genome has the potential to improve poultry production and offer a powerful 
bioreactor for the production of pharmaceutical and industrial proteins in eggs. However, before realizing 
this, the methods for producing transgenic poultry must become routine. The direct modification of an 
embryo with DNA or viral vectors is possible, but this approach does not have the ability to make 
locus-specific modifications to the genome. To overcome this problem, several cell-based protocols, 
which use mainly blastodermal cells (BDCs), embryonic stem cells (ESCs), primordial germ cells (PGCs) 
and spermatogonial stem cells (SSCs) have been developed to generate transgenic chickens. At present, 
the complete system for isolating, expanding, transfecting, selecting and re-expanding embryonic stem 
cell cultures and the subsequent production of high-grade somatic chimeras has been reported, but 
germline chimeras with transgenic progeny have not yet been achieved. Although the use of viral 
systems can achieve highly efficient gene transfer, the potential safety issues may limit their practical 
application. Among the many possible permutations and combinations of target cell and gene transfer 
methods described in this review, targeting SSCs in vitro using non-viral-based gene transfer and 
re-injecting them to cock testis is the most efficient and cost-effective strategy to produce transgenic 
poultry. 
 





Significant progress during the last two decades has 
improved our understanding of the molecular basis of the 
genetics of growth and development. This knowledge, 
coupled with transgenic techniques, has the potential to 
accelerate conventional poultry breeding programs for 
improvements in desirable production traits (e.g. egg 
production, feed efficiency, rate of gain and body com- 
position). Compared to mammals, avian species such as 
chicken and quail are easy to raise and have short 
reproductive cycles and high egg production; therefore, 
they are particularly amenable to transgenics for the 
production of pharmaceutical and industrial proteins in 
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ques for producing transgenic poultry has lagged 
somewhat behind that for mammals. This is due primarily 
to the differences in the reproductive systems of avian 
species, the processing of the egg as it passes down the 
oviduct, the need for the shell in development and the 
difficulty of isolating germ or embryonic stem cells 
(Mozdziak and Petitte, 2004; van de Lavoir et al., 2006a; 
Fabrice and Bertrand, 2010). Nevertheless, in the past five 
years, some important breakthroughs have been achieved, 
making transgenic technology in poultry more efficient 
and thus, more useful for a broader spectrum of 
applications (Scott and Lois, 2005; van de Lavoir et al., 
2006b; Kalina et al., 2007; Kwon et al., 2008; Shiue et al., 
2009; Motono et al., 2010; Yu et al., 2010). The objective 
of this review is to present the status of technologies used 




TRANSGENIC TECHNOLOGY IN POULTRY 
 
An efficient technology that enables  the  production  of  




transgenic birds at high frequency with reliable expression 
of transgenes is the prerequisite of application to both 
basic research and biotechnology. Two different strategies 
have been used to generate transgenic birds in most 
previous studies: (1) The direct modification of the embryo 
with DNA or viral vectors and (2) indirect cellular approaches, 
using mainly blastodermal cells (BDCs), embryonic stem 
cells (ESCs), primordial germ cells (PGCs) and sperma- 
togonial stem cells (SSCs).  
 
 
Direct protocols to generate transgenic poultry using 
DNA or viral vectors 
 
In early studies, some investigators preferred to replicate 
the protocol developed in mice and applied successfully in 
several mammalian species, which involved pronuclear 
injection of newly fertilized eggs to produce transgenic 
poultry (Love et al., 1994). However, this protocol has 
some obvious drawbacks. First, the method is incon- 
venient and costly because every time one-cell eggs are 
harvested, a mature female bird must be killed, making it 
difficult to obtain a sufficient number of eggs to complete 
any procedure aimed at generating transgenic birds. 
Second, this protocol is technically demanding because 
after each injection, the ovum must be cultured ex vivo or 
transferred into a female bird to obtain a live bird. Both of 
these manipulations require a significant level of technical 
skill and an infrastructure to support the ex vivo culture 
system. 
To avoid these disadvantages, other researchers have 
developed several efficient approaches through the direct 
manipulation of the embryo at two key stages of 
development: (1) the embryo in newly laid fertilized eggs 
at the blastodermal stage (stage X) and (2) embryos that 
have reached ~72 h of incubation, when the primordial 
germ cells (PGCs) and the precursors of the gametes, 
can be accessed. In 2001, Mizuarai et al. (2001) 
generated transgenic quail with highly efficient germline 
transmission (80%) by directly injecting a 
replication-defective pantropic retroviral vector into newly 
laid eggs at the blastodermal stage. Later, Kwon et al. 
(2004) also produced transgenic chickens using similar 
methods. Moreover, subsequent studies on detection 
showed that the EGFP gene was expressed in various 
body parts, including head, limb, eye, toe and several 
internal organs. Several years later, based on this system, 
Kwon and colleagues (2008) once again generated 
transgenic chickens that produced human granulocyte 
colony-stimulating factor (hG-CSF), and the biological 
activity of this recombinant hG-CSF was significantly 
higher than that of its commercial counterpart derived 
from Escherichia coli. Although the successful germline 
transmission of the transgene was confirmed in G1 
progeny, most of them died within 1 month of hatching.  
To improve both the efficiency of gene expression and 





the optimal developmental stage for viral vector injection. 
Masamichi et al. (2005) have reported that the maximal 
level of transgene expression could be obtained by 
injecting a replication-defective retroviral vector into the 
heart of embryos after 55 h of incubation. Likewise, 
Kawabe et al. (2008) also found that both the transduction 
efficiency and transgene expression were the highest 
when the viral solution was injected into embryos at a 
similar stage (stages 14 – 15). Both studies suggested 
that PGCs migrating into the gonads from the 
bloodstream are effective viral targets for generating 
transgenic chickens using retroviral vectors. Based on 
previous reports, in short, we could conclude that the 
appropriate development stage of embryo in combination 
with replication-incompetent retroviral or lentiviral gene 




Indirect protocols to generate transgenic poultry via 
genetically modified cells in vitro 
 
Although the direct modification of an embryo with DNA or 
viral vectors can produce transgenic poultry, this 
technique does not have the ability to make locus-specific 
modifi- cations (gene targeting) to the genome because 
the transgene is integrated randomly into the host 
chromosomes (van de Lavoir et al., 2006). One obvious 
drawback of this strategy is that it probably causes 
variable expression of the transgenes in the host due to 
positional effects related to the chromosomal sites of 
integration. For this reason, the use of gene targeting is 
particularly attractive for the production of transgenic 
poultry because the possibility of obtaining a predictable 
phenotype that is of commercial importance is better than 
having to evaluate several lines of birds produced through 
random integration of the transgene (Dodgson, 2007). In 
view of this, a cell-based strategy may provide an 
alternative method for creating genetically modified 
poultry. Due to the culture of cells, the use of this 
approach not only provides sufficient materials for 
transgenic manipulation, but also allows the selection of 
cells that have integrated the transgene and cells that 
undergo targeted changes to the genome through the 
selection of homologous recombination events (Jung et 
al., 2007; Fabrice and Bertrand, 2010). From a practical 
perspective, clearly, this strategy can reduce the number 
of birds required to isolate transgenic birds and reduce the 
time required for assessment of the transgenic phenotype 
by one generation. Several viable protocols via cell-based 
strategy for the production of transgenic chicken are 
illustrated in Figure 1.  
To date, several kinds of cells have been cultured in 
vitro for the production of transgenic poultry: (1) BDCs or 
ESCs isolated from the blastodisk immediately after 
oviposition (Pain et al., 1996; Park et al., 2006; Wang et 
al., 2006), (2) PGCs isolated from developing embryos 
(Zhao and Kuwana, 2003; Mozdziak et al., 2005; Shiue et  






Figure 1. Diagram of methods that have been used for the production of transgenic chicken via cell-based strategy. These 
methods involve several major steps for targeted modifications to the genome. (1) To obtain cells that will contribute to the germline 
from the embryo or cock’s testis and culture them in conditions that keep the cells in a relatively undifferentiated status; (2) these 
cells are transfected with viral or non-viral vectors designed to allow homologous recombination, and cells in which the correct 
recombination event has occurred are selected and expanded in vitro; (3) injecting genetic modified cells into the bloodstream of 




al., 2009) and (3) SSCs isolated from the testes of cocks 
(Wu et al., 2006; Jung et al., 2007). 
 
 
Blastodermal cells and embryonic stem cells 
 
The technique for obtaining germline chimeras by  direct  
modification of the embryo at the blastodermal stage 
(stage X) has been well established in both chicken and 
quails (Mizuarai et al., 2001; Kwon et al., 2004; McGrew 
et al., 2004; Koo et al., 2006). Moreover, some reports 
have indicated that blastodermal cells are amenable to 
transfection using various methods such  as  liposomes  




and viral vectors (Wang et al., 2006). For instance, Zhu et 
al. (2005) have developed a cell transplantation method in 
chicken, wherein human monoclonal antibody were 
purified from the eggs of somatic chimeras after 
introducing transfected blastodermal cells into stage-X 
embryo. However, there is no report as yet that 
blastodermal cells of the bird that have been cultured in 
vitro for more than a week contribute to the germline 
chimeras, even though they apparently make up 
approaching 100% of the somatic cells of the chimera. To 
the cause of this, we think it is possible that during the 
long-term in vitro culture, these transfected BDCs have 
lost the ability to contribute to germline tissues. 
To facilitate the germline transmission, some research 
groups have attempted to isolate pluripotent embryonic 
stem cells from the avian species, because pluripotent 
embryonic stem cells are undifferentiated cells capable of 
proliferation in cell culture and self-renewal and have the 
ability to differentiate into all somatic cell types and the 
germ line (van de Lavoir et al., 2006b). In the past, most 
efforts to culture avian embryonic stem cells have focused 
on the stage X non-incubated blastodermal cells, because 
within this population exist some cells that have the ability 
to enter the germline. For instance, Pain et al. (1996) 
study showed that chicken early blastoderm contains cells 
characterized as putative avian embryonic stem (ES) cells 
that can be maintained in vitro for long-term culture. 
These cells exhibit features similar to those of murine ES 
cells such as typical morphology, strong reactivity toward 
specific antibodies, cytokine-dependent extended 
proliferation and high telomerase activity. These cells also 
present high capacities to differentiate in vitro into various 
cell types including cells from ectodermic, mesodermic 
and endo- dermic lineages. At present, the complete 
system for isolating, expanding, transfecting, selecting and 
re-expanding ES cell cultures and the subsequent 
production of high- grade chimeras has been reported 
(van de Lavoir et al., 2006a). Up to date, however, there 
are no reports that exist about using transfected avian 
ESCs to generate germline chimeras with transgenic 
progeny (Fabrice et al., 2009) (Figure 1). Previous study 
once demonstrated that blastodermal cells can gradually 
transform into ESC-like cells during in vitro culture, while 
losing large amounts of lipid vesicles from the cytoplasm 
(Park et al., 2006). From these studies, we can conclude 
that although ESC can be easily amplified in vitro and 
genetically modified but it is still unknown under what 
culture conditions chicken ESCs would be able to keep 
long-term germinal competency once maintained in 
long-term in vitro culture. 
 
 
Primordial germ cells 
 
PGCs are the progenitor cells of ova and spermatozoa 
and are the genetic link among generations (Mozdziak et 





of the area pellucida in the stage X blastoderm (freshly 
laid eggs). Upon incubation and as development 
continues, they can be found in the extra-embryonic 
region called the germinal crescent. They then enter and 
circulate in the blood vessels of the embryo, and migrate 
to the gonadal ridges, which develop into the mature 
gonads (Nakamura et al., 2007). It is generally thought 
that the migration is assisted by the extracellular matrix, 
which acts as a substrate containing adhesion molecules 
along the migratory path of PGC to the gonadal ridge 
(D'Costa et al., 2001). This unique feature, the migration 
of PGCs through the bloodstream and commitment to the 
germline, facilitates the production of germline chimeras 
via the injection of allogenic or xenogenic pluripotent cells 
into the blood vessels of the recipient embryos. Moreover, 
some experi- ments have demonstrated that isolated 
PGCs could be transferred to other recipient embryos at 
the stages in which PGCs circulate in the blood, without 
losing the ability to contribute to the formation of germ 
cells (Naito et al., 1999; Kim et al., 2004; Mozdziak et al., 
2006). Therefore, it is assumed that gene transfer to 
PGCs and then trans- plantation to recipient embryos is 
an alternative way to generate transgenic birds. 
Furthermore, it is expected that the use of PGCs may 
improve the efficiency of germline transmission since 
PGCs are progenitors of ova and spermatozoa. Due to 
these reasons, a number of researches have focused on 
PGCs, instead of BDCs or ESCs, as a way to generate 
transgenic birds.  
To date, there have been some successful reports 
using PGCs for transgenic research. van de Lavoir et al., 
(2006b) have successfully produced transgenic chickens 
using embryonic blood derived PGCs. In addition, this 
study also presents a robust system that allows PGCs in 
culture for extended periods and can be genetically 
manipulated while retaining their commitment to the germ 
line. The advent of this technology provides the ability to 
introduce transgenes of any size and to make site-specific 
changes to the genome. However, the scarcity of PGCs 
retrieved from embryonic blood (as low as 0.05% of total 
blood cells) still limited technical feasibility of PGCs for 
more advanced manipulation for transgenesis (Park et al., 
2003). To resolve this problem, some research groups 
have attempted to isolate PGCs from the embryonic 
gonads instead of the circulatory system. Kim et al. (2005) 
reported the successful production of quail germline 
chimera by transfer of gPGCs immediately after collection. 
Subsequently, they also found that the capacity of gPGCs 
to induce germline transmission was not decreased by 
culturing for extended periods in vitro prior to trans- 
plantation (Park et al., 2008). Similarly, Shiue et al. (2009) 
recently also established a robust culture system maintain 
chicken gPGCs for long-term in vitro culture without losing 
their capacity to express pluripotent markers and to 
integrate into the gonads. In order to optimize conditions 
for the establishment of transgenic chickens, Motono et al. 





from 2.5- and 5.5-day embryos in migrating to the 
recipients' gonads and succeeded in establishing 
transgenic progeny using gPGCs infected with a lentiviral 
vector. 
To further enhance the efficiency of germline transmission 
and genetic modification, some effective methods have 
also been widely employed in recent years. One approach 
is to purify PGCs by nycodenz density gradient centri- 
fugation (Zhao and Kuwana, 2003) or magnetic cell 
sorting (Kim et al., 2004, 2005). The other is to sterilize 
the recipient embryos using busulfan emulsion (Furuta 
and Fujihara, 1999) or gamma-ray irradiation device (Lim 
et al., 2006) since the percentage of the transferred PGCs 
to the whole PGC population (transferred plus 
endogenous) is one important factor determining the 
efficiency of obtaining transgenic progeny. 
 
 
Spermatogonial stem cells 
 
In previous studies, most transgenic protocols were using 
BDCs, ESCs or PGCs as the mediated cells to produce 
transgenic birds. These protocols, however, are 
time-consuming and laborious, because they all need to 
massively produce founder stocks and to maintain the 
founders until sexual maturation for testcross analysis of 
the progenies derived from manipulated embryo (Li et al., 
2008). To facilitate the production of transgenic poultry, 
many investigators have directed their attention toward 
developing an alternative germline chimera production 
system that operates via SSCs rather than through BDCs, 
ESCs or PGCs. Since early study in mice have indicated 
that testicular cells contain a small proportion of SSCs, 
which are the precursor cells for spermatogenesis and 
can be genetically modified in vitro and transplanted into 
seminiferous tubules of recipients (Kanatsu-Shinohara et 
al., 2003; Hamra et al., 2005). Furthermore, the work 
done by Jung et al. (2007) also identified SSCs in chicken 
testicular cells. This system could create a local chimeric 
state in the testes, and eliminate the background of 
mosaic animals and produce hemizygously transgenic 
animals in G1 generation. Pavel et al. (2006) for the first 
time in birds validated that the transfer of dispersed 
testicular cells from fertile donor cocks results in the 
recolonization of recipient testes previously sterilized by 
repeated radiation treat- ments. These recipient cocks 
ultimately produced viable and fertilization-competent 
spermatozoa. Similar results were also obtained by Lee et 
al. (2006) but with a low chimeric efficiency (7.8%). These 
studies suggest a possibility that efficient gene delivery 
into the crude mix of testicular cells might target the SSCs 
and pave way for bird transgenesis. Recently, Kalina et al. 
(2007) demonstrated that chicken testicular cells could be 
efficiently infected in vitro with a replication-defective 
reporter retrovirus vector pantropized by vesicular 
stomatitis virus envelope glycol-protein (VSV-G). 
Moreover, all cell types present in the mix  of  testicular  




cells express the transduced reporter enhanced green 
fluorescent protein (EGFP) after in vitro cultivation and 
freshly explanted infected testicular cells restore 
spermatogenesis in sterilized recipient cockerels.  
For improving the efficiency of germline transmission 
and genetic modification of SSCs in vitro, Wu et al. (2006) 
first developed a method for SSCs isolation, purification 
and culture in vitro. Based on this system, their colleagues 
also established a highly efficient protocol to produce 
transgenic chickens by directly injecting transfected SSCs 
into the cock’s testis (Li et al., 2008) (Figure 1). Likewise, 
Yu et al. (2010) recently, also isolated chicken SSCs from 
fetal testes, and cultured them more than 2 months after 
purification in vitro. Moreover, they found that transferred 
SSCs could stably localize to the basal membrane, 
prolife- rate and differentiate into sperm. This simple and 
efficient method provides a new way to produce 
transgenic chicks on a large scale. All these studies 
suggest that it is a feasible approach to produce 
transgenic birds using SSCs. 
 
 
PROTOCOLS FOR GENE TRANSDUCTION 
 
All methods for producing transgenic poultry rely on 
techniques designed to transfer foreign genes into target 
cells. The first methods developed for gene transfer in 
poultry were based on the use of avian retroviruses: 
replication-competent vectors derived from avian leucosis 
virus (Salter et al., 1986) and replication-defective vectors 
derived from reticuloendotheliosis virus (Bosselman et al., 
1989). Since then, retroviral vectors have become a 
common gene transfer vehicle for bird cells. Retroviruses 
vector are small RNA viruses that, upon infection of 
dividing cells, are reverse-transcribed into DNA and then 
integrated into the host genome and passed down from 
generation to gene- ration (Mozdziak and Petitte, 2004). 
For use in transgenics, nonessential parts of the viral 
genome are replaced with the gene for transfer, which is 
subsequently inserted into the host genome along with 
viral sequences. To date, many researchers have 
successfully produced transgenic chickens or quail using 
retrovirus vectors (Harvey et al., 2002; Masamichi et al., 
2005; Koo et al., 2006; Kawabe et al., 2008; Kamihira et al., 
2009). Nonetheless, DNA transfer by a retrovirus has some 
limitations, including: (1) the upper limit of the introduced 
DNA fragment is <8 kb; (2) the transgene only integrates 
into dividing cells; (3) specific target cells must be 
recognized; and (4) the process is characterized by high 
susceptibility to gene silencing. In order to overcome 
some of these limitations, a new group of vectors, derived 
from the lentivirus class of retroviruses, has been 
developed. These lentiviral vectors do not require dividing 
cells for their integration because the import of their 
genetic information into the host cell is independent of 
cellular division, and they have a wide spectrum of target 
hosts  cells  (Cockrell and Kafri, 2007).  In  addition, in  




recent years, lentivirus systems have been improved for 
tissue-specific expression. In 2005, Scott and Lois were 
successful in producing transgenic quail expressing the 
GFP gene using lentiviral vectors. Furthermore, they 
found that the GFP expression was specific to neurons 
and consistent across multiple generations. This 
approach provides a powerful tool for tissue-specific 
expression of desired transgenes or directed knockout of 
deleterious genes in birds. Since then, several classes of 
lentiviral vectors have been used to produce transgenic 
birds; some results have resulted in estimates that the 
production frequency of transgenic founders using these 
vectors is 10- to 100-fold higher than that obtained using 
the previous methods (Chapman et al., 2005; Motono et 
al., 2010). Moreover, to date, few studies have found the 
incidence of gene silencing or the loss of transgene 
expression over time or generations.  
Despite extraordinary progress, the use of viral systems 
still has certain drawbacks, e.g., the potential safety 
issues, the possible integration of retroviruses in close 
proximity to potential oncogenes, followed by the 
activation of these oncogenes, and the initiation of 
conversion of a normal cell into a tumor cell (Cockrell and 
Kafri, 2007). In this situation, several non-viral-based 
technologies for gene transfer have been described 
including microinjection, liposome transfer, 
electroporation and calcium acid phosphate precipitation. 
DNA microinjection into the pronucleus of newly fertilized 
chicken eggs has been reported since 1994, but so far, it 
has not been used widely in poultry due to its low transfer 
efficiency and the laboriousness of the procedure, as 
described above (Love et al., 1994). In contrast, the 
liposome transfer method can be applied widely to 
transfer foreign genes efficiently into cells and embryos 
(Wang et al., 2006; Suraeva et al., 2008). Never- theless, 
a recent study on in vitro SSC transfection showed that 
both the efficiency of transfection and cell survival rate 
were higher using electroporation rather than liposomes 
or calcium acid phosphate (20.52 versus 9.75 and 5.61; 






Transgenic techniques have several possible applications 
in poultry industry, including production of valuable bioactive 
proteins and accelerating conventional breeding 
programs for improvements in desirable production traits. 
Owing to special physiological and developmental 
characteristics of the bird, in addition, these techniques 
have also been used to transfer foreign genetic materials 
into the chicken embryo to investigate the function of gene 
involved in vertebrate development (Brown et al., 2003; 
Hen et al., 2006; Raman et al., 2006). In previous studies, 
nevertheless, the objectives of the most transgenic works 





produce some recombinant proteins. This is because 
transgenic poultry bioreactor system, compared with 
using plants, microorganisms and mammalian, has 
several advantages. Firstly, poultry has high protein 
productivity in eggs, and more than half of which comes 
from the expression of a single gene (ovalbumin gene), so 
it is easy to obtain large amounts of recombinant protein 
with a high purity (Robert, 2006). Secondly, the 
glycosylation patterns of some human proteins are more 
similar to those of chicken than to other bioreactor system 
(Raju et al., 2000). Thirdly, the presence of natural 
protease inhibitors in egg content and the natural sterile 
microenvironment of the egg system provided an ideal 
environment for stabilizing the biological activity of foreign 
proteins (Rapp et al., 2003). In addition, some previous 
studies indicated that the production of some proteins that 
are toxic for mammals could some- times be realized in 
transgenic birds only (Zhu et al., 2005; Lillico et al., 2007). 
The first successful production of a recombinant protein 
in eggs was achieved using replication-defective avian 
leucosis virus (ALV) to deliver the transgene (Harvey et al., 
2002). In this experiment, the biologically active bacterial 
-lactamase was secreted into the serum and egg white 
of four generations of transgenic chickens, and the 
expression levels were similar in successive generations. 
This study supports the potential of the chicken as a 
bioreactor for the production of commercially valuable and 
biologically active proteins in egg white. Since then, 
several kinds of recombinant proteins, such as antibodies, 
enzymes and cytokine, were produced in the eggs using 
transgenic chickens or quails as the bioreactor. Recently, 
Lilico et al. (2007) demonstrated that transgenic chicken 
could produce large quantities of biologically active 
pharma- ceutical proteins in egg white by using 
oviduct-specific expression promoter, without any 
evidence of transgene silencing after several generations of 
germline transmission. Similarly, Kamihira et al. (2009) 
also generated transgenic chickens that can produce 
whole antibodies in both egg white and yolk throughout 
the breeding period. From previous reports, we can 
conclude that most of recom- binant proteins in the eggs 
were produced through two possible strategies. One is to 
introduce a transgene to oviduct cells that produce egg 
proteins (Harvey et al., 2002; Zhu et al., 2005). This 
includes the use of either tissue- specific promoters such 
as an ovalbumin promoter or constitutive promoters. The 
other possible strategy is to produce target proteins 
containing the Fc region of an antibody into blood, leading 
to the accumulation of the proteins into the yolk via IgY 
transfer (Kawabe et al., 2006; Lilico et al., 2007; Kyogoku 
et al., 2008; Kamihiraa et al., 2009). In the latter case, 
although target proteins may be limited to antibodies and 
Fc-fusion proteins, the method is effective for recovering 
such proteins at least without sacrificing the birds. All of 
these works mentioned above support the potential for 
efficient generation of transgenic birds and the 










Technologies for the production of transgenic poultry and 
protocols for the transgenic manipulation of gene expression 
have advanced considerably over the past decade and 
have had an important impact on basic research and 
poultry industries. Nevertheless, some major problems or 
drawbacks remain to be solved before the production of 
transgenic poultry becomes commonplace. Generally, it is 
considered that BDCs cultured for extended periods could 
transform into ESC-like cells. To date, however, there has 
been no report of the successful production of germline 
chimeras in birds using these ESC-like cells. Therefore, 
further research is required to conclusively establish and 
characterize bird ESCs to exploit their plasticity and ability 
to dedifferentiate in transgenic research. Apart from these 
problems, the increasing public concern regarding the 
safety of products derived from transgenic poultry may 
also restrict the practical application of some efficient 
viral-mediated transgenic technologies in the future. 
Under this circumstance, we believe that among the many 
possible permutations and combinations of target cell and 
gene transfer methods currently available, targeting SSCs 
in vitro using non-viral-based gene transfer and re- 
injecting them into cock testis is the most efficient and 
cost-effective strategy to produce transgenic poultry. 
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